Cargando…

Shortened treatment regimens versus the standard regimen for drug‐sensitive pulmonary tuberculosis

BACKGROUND: Tuberculosis causes more deaths than any other infectious disease worldwide, with pulmonary tuberculosis being the most common form. Standard first‐line treatment for drug‐sensitive pulmonary tuberculosis for six months comprises isoniazid, rifampicin, pyrazinamide, and ethambutol (HRZE)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grace, Angeline G, Mittal, Abhenil, Jain, Siddharth, Tripathy, Jaya P, Satyanarayana, Srinath, Tharyan, Prathap, Kirubakaran, Richard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Ltd 2019
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6953336/ https://www.ncbi.nlm.nih.gov/pubmed/31828771 http://dx.doi.org/10.1002/14651858.CD012918.pub2

Ejemplares similares

Cost-effectiveness of GeneXpert and LED-FM for diagnosis of pulmonary tuberculosis: A systematic review
por: Sagili, Karuna D., et al.
Publicado: (2018)

Shortened tuberculosis treatment regimens: what is new?
por: Silva, Denise Rossato, et al.
Publicado: (2020)

Treatment-shortening regimens for tuberculosis: updates and future priorities
por: Saluzzo, Francesca, et al.
Publicado: (2023)

Active Case Finding for Tuberculosis in India: A Syntheses of Activities and Outcomes Reported by the National Tuberculosis Elimination Programme
por: Burugina Nagaraja, Sharath, et al.
Publicado: (2021)

Analysis of Combination Drug Therapy to Develop Regimens with Shortened Duration of Treatment for Tuberculosis
por: Drusano, George L., et al.
Publicado: (2014)

Optimizing tuberculosis treatment efficacy: Comparing the standard regimen with Moxifloxacin-containing regimens
por: Budak, Maral, et al.
Publicado: (2023)

Treatment outcome of standardized regimen in patients with multidrug resistant tuberculosis
por: Jain, Kalpesh, et al.
Publicado: (2014)

A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosis
por: Imperial, Marjorie Z., et al.
Publicado: (2018)

Mycobacterium tuberculosis precursor rRNA as a measure of treatment-shortening activity of drugs and regimens
por: Walter, Nicholas D., et al.
Publicado: (2021)

Prospective Randomization Trial of G-CSF-Primed Induction Regimen versus Standard Regimen in Patients with AML
por: Lee, Yoo Jin, et al.
Publicado: (2011)

Effects on the QT Interval of a Gatifloxacin-Containing Regimen versus Standard Treatment of Pulmonary Tuberculosis
por: Olliaro, Piero L., et al.
Publicado: (2017)

Publisher Correction: A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosis
por: Imperial, Marjorie Z., et al.
Publicado: (2018)

Predictive Modeling to Study the Treatment-Shortening Potential of Novel Tuberculosis Drug Regimens, Toward Bundling of Preclinical Data
por: Mudde, Saskia E, et al.
Publicado: (2021)

Outcomes associated with standardized treatment regimens for extensively drug-resistant tuberculosis
por: Aggarwal, Anivita, et al.
Publicado: (2020)

Optimization of dosing regimens of isoniazid and rifampicin in children with tuberculosis in India
por: Aruldhas, Blessed Winston, et al.
Publicado: (2019)

Non-inferiority of reverse hybrid regimen versus standard concomitant regimen for H. pylori eradication in a randomized-controlled trial
por: Valizadeh Toosi, Seyed Mohammad, et al.
Publicado: (2023)

What’s Next for the Standard Short-Course Regimen for Treatment of Multidrug-Resistant Tuberculosis
por: Campbell, Jonathon R., et al.
Publicado: (2019)

Economic evaluation of a shortened standardised treatment regimen of antituberculosis drugs for patients with multidrug-resistant tuberculosis (STREAM): study protocol
por: Gama, Elvis, et al.
Publicado: (2016)

Triplet Therapy in Metastatic Castrate Sensitive Prostate Cancer (mCSPC)—A Potential New Standard of Care
por: Mittal, Abhenil, et al.
Publicado: (2023)

Strategies to detect and manage latent tuberculosis infection among household contacts of pulmonary TB patients in high TB burden countries ‐ a systematic review and meta‐analysis
por: Sagili, Karuna Devi, et al.
Publicado: (2022)

Possible impact of the standardized Category IV regimen on multidrug-resistant tuberculosis patients in Mumbai
por: Udwadia, Zarir F, et al.
Publicado: (2016)

Effectiveness and safety of Levofloxacin containing regimen in the treatment of Isoniazid mono-resistant pulmonary Tuberculosis: a systematic review
por: Inbaraj, Leeberk Raja, et al.
Publicado: (2023)

Initial steroid regimen in idiopathic nephrotic syndrome can be shortened based on duration to first remission
por: Baek, Hee Sun, et al.
Publicado: (2015)

Evaluating systematic reviews in urology: A practical guide
por: Tharyan, Prathap
Publicado: (2007)

Criminals in the Citadel and Deceit all along the Watchtower: Irresponsibility, Fraud, and Complicity in the Search for Scientific Truth
por: Tharyan, Prathap
Publicado: (2012)

THE RELEVANCE TO META-ANALYSIS, SYSTEMATIC REVIEWS AND THE COCHRANE COLLABORATION TO CLINICAL PSYCHIATRY
por: Tharyan, Prathap
Publicado: (1998)

IS MONITORING OF PLATELETS NECESSARY DURING CLOZAPINE THERAPY ?
por: Tharyan, Prathap
Publicado: (1999)

THARYAN ET AL'S REPLY
por: Tharyan, Prathap
Publicado: (1995)

Low-intensity regimens versus standard-intensity induction strategies in acute myeloid leukemia
por: Vey, Norbert
Publicado: (2020)

Is Chemoprophylaxis for Child Contacts of Drug-Resistant TB Patients Beneficial? A Systematic Review
por: Padmapriyadarsini, C., et al.
Publicado: (2018)

Nevirapine- versus Efavirenz-based antiretroviral therapy regimens in antiretroviral-naive patients with HIV and Tuberculosis infections in India: a multi-centre study
por: Sinha, Sanjeev, et al.
Publicado: (2017)

Regimen
Publicado: (1856)

Regimen
Publicado: (1868)

Regimen
Publicado: (1860)

Regimen
Publicado: (1882)

Regimen
Publicado: (1881)

Regimen
Publicado: (1878)

Effectiveness of the Standard WHO Recommended Retreatment Regimen (Category II) for Tuberculosis in Kampala, Uganda: A Prospective Cohort Study
por: Jones-López, Edward C., et al.
Publicado: (2011)

Cost Effectiveness of a Shorter Moxifloxacin Based Regimen for Treating Drug Sensitive Tuberculosis in India
por: Muniyandi, Malaisamy, et al.
Publicado: (2022)

Standardizing Chemotherapy Regimen Nomenclature: A Proposal and Evaluation of the HemOnc and National Cancer Institute Thesaurus Regimen Content
por: Rubinstein, Samuel M., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_skn1f1htt52l3p47adok884q58